Date
- 2026 (1)
- 2025 (15)
- 2024 (11)
- 2023 (7)
- 2022 (30)
- 2021 (10)
- 2020 (27)
- 2019 (7)
- 2018 (27)
- 2017 (26)
- 2016 (5)
- 2015 (57)
- 2014 (6)
- 2013 (4)
- 2012 (13)
- 2011 (6)
- 2010 (5)
- 2009 (7)
- 2008 (2)
- 2007 (3)
- 2006 (1)
- 2005 (14)
- 2004 (3)
- 2002 (2)
- 2001 (5)
- 2000 (7)
- 1999 (1)
- 1998 (3)
- 1997 (5)
- 1996 (3)
- 1995 (1)
- 1994 (4)
- 1993 (3)
- 1992 (2)
- 1991 (12)
Sponsor content
335 result(s) found, displaying 111 to 120
-
Cancellation by sponsorRequested by Johnson & Johnson Pacific Pty Ltd
-
Cancellation by sponsorRequested by Johnson & Johnson Pacific Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NICORETTE FRUITDROPS nicotine 4mg (as nicotine polacrilex) lozenge bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NICORETTE FRUITDROPS nicotine 2 mg (as nicotine polacrilex) lozenge bottle.
-
Cancellation or suspensionRegulatory action due to The good had become an exempt good under Schedule 5, Item 14 of the Regulations. Exempt goods are not required to be included on the ARTG (paragraph 18(1) of the Act)., effective 26/05/2020
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MYLANTA ANTACID ORIGINAL oral liquid bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MYLANTA ANTACID DOUBLE STRENGTH oral liquid bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MICROLAX ORAL LIQUID liquid paraffin 4.83mL/15mL bottle.
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020
-
Cancellation or suspensionRegulatory action due to Under subsection 29D(1)(b); it is likely there are grounds for cancelling this medicine from the ARTG under section 30(2)(a) on the basis that the quality of the goods is unacceptable., effective 28/01/2020